Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Otol Neurotol ; 25(3): 353-8, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15129117

RESUMEN

OBJECTIVE: To investigate the occurrence of benign paroxysmal positional nystagmus in subjects undergoing treatment with potentially ototoxic medications. STUDY DESIGN: Prospective and retrospective record reviews. SETTING: Tertiary referral neurotology clinic; clinical research and technology center. SUBJECTS: Ninety-nine hospitalized subjects undergoing treatment of infectious disease or carcinoma with potentially ototoxic medications. INTERVENTIONS: Records review, tests of vestibular function. MAIN OUTCOME MEASURE: Results of Hallpike positional tests for benign paroxysmal positional nystagmus (electro-oculography). RESULTS: Forty-one (41%) of 99 subjects were female and 58 (59%) were male. Age range was 15 to 73 years (mean, 47 years). Forty-nine (50%) of 99 subjects had an unequivocally positive Hallpike test for benign paroxysmal positional nystagmus in one or both ears. The occurrence of benign paroxysmal positional nystagmus in the Hallpike-positive population was distributed equally across age decades. Of the 49 subjects with benign paroxysmal positional nystagmus, 22 (44%) were female and 27 (56%) were male. CONCLUSIONS: Benign paroxysmal positional nystagmus is the most common cause of vertigo in the general population, including subjects receiving ototoxic drugs. Complaints of vertigo in subjects receiving ototoxic drugs therefore may or may not indicate onset of ototoxicity. Occurrence of benign paroxysmal positional nystagmus in subjects receiving ototoxic drugs was independent of gender or age. The high occurrence rate of benign paroxysmal positional nystagmus in subjects receiving potentially ototoxic medications is consistent with the observation that benign paroxysmal positional nystagmus occurs in combination with many pathologic conditions. Benign paroxysmal positional nystagmus presenting in subjects receiving ototoxic drugs may complicate the clinical identification of ototoxicity and obfuscate clinical decision-making processes.


Asunto(s)
Aminoglicósidos/efectos adversos , Antiinfecciosos/efectos adversos , Antineoplásicos/efectos adversos , Cisplatino/efectos adversos , Nistagmo Patológico/inducido químicamente , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nistagmo Patológico/complicaciones , Estudios Prospectivos , Estudios Retrospectivos , Vértigo/etiología , Pruebas de Función Vestibular
2.
Curr Opin Otolaryngol Head Neck Surg ; 11(5): 355-60, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14502066

RESUMEN

PURPOSE OF REVIEW: This article reviews current literature pertaining to vestibular adaptation and rehabilitation. RECENT FINDINGS: Properly conducted and supervised vestibular rehabilitation therapy ameliorates a wide variety of peripheral and central balance disorders in patients of all ages. The best outcomes result from individualized vestibular rehabilitation therapy programs that correct or compensate for the negative impact of specific vestibular functional deficits and comorbid conditions on patient function. Comorbid conditions such as anxiety, depression, and cognitive dysfunction may affect vestibular rehabilitation therapy outcome. As objective postural instability improves in response to vestibular rehabilitation therapy, self-reported handicap lessens. SUMMARY: Successful vestibular rehabilitation therapy improves activities of daily living and reduces fall risk.


Asunto(s)
Actividades Cotidianas , Terapia Ocupacional , Enfermedades Vestibulares/rehabilitación , Humanos , Resultado del Tratamiento , Enfermedades Vestibulares/psicología , Enfermedades Vestibulares/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA